Clinical Characteristics of Asthmatic Patients Prescribed Various β-Agonist Metered-Dose Inhalers at Yamagata University Hospital

スポンサーリンク

概要

• 論文の詳細を見る

• To determine the prescription characteristics of β-agonist metered-dose inhalers (MDI), we retrospectively investigated all prescriptions containing one of five types of β-agonist MDIs available at Yamagata University Hospital in 1997, as well as patients’ characteristics. The total number of asthmatic patients was 225 (age, 11-79, mean, 47.2) in 1997. Fenoterol MDI was prescribed to patients who visited the hospital at regular periods and had more severe asthma. Isoprenaline MDI also was not prescribed for first-time patients. Patients who were prescribed tulobuterol MDI had mild or moderate asthma and some of them were only occasional or first-time visitors. Salbutamol and procaterol MDIs were also prescribed for first-time patients; however, tulobuterol MDI was the most frequently prescribed for first-time patients. Patients prescribed fenoterol and isoprenaline MDIs had adequate knowledge of proper asthma management, because sufficient information had been provided about the use of MDIs in the past. Patients prescribed tulobuterol MDI should be provided with detailed instructions because they had little knowledge of handling MDIs and self-management of asthma as many of them were first or intermittent visitors. Patients prescribed salbutamol or procaterol MDIs should be evaluated regarding their past medications and some of them should be instructed regarding the use of the MDI. Although these clinical aspects might be applicable only to our hospital, the same or other prescription patterns will be found in other hospitals and/or by other physicians. Adequate instructions to individual patients who are prescribed a particular β-agonist MDI should be provided by the medical staff, especially to outpatients, to reduce hospitalization and death from asthma.

• 公益社団法人　日本薬学会の論文
• 2001-01-01

著者

• Ojima Fumiyoshi

  Department Of Pharmacy Yamagata University Hospital

• Nakagawa Y

  Department Of Pharmacy Yamagata University Hospital

• Nakagawa Yoshito

  Department Of Pharmacology Niigata University School Of Medicine

• Nakamura Hidenori

  First Department Of Internal Medicine Yamagata University Medical School

• Nakamura Hidenori

  First Department Of Internal Medicine Yamagata University School Of Medicine

• Shoji Tohru

  Department Of Pharmacy Yamagata University Hospital

• EBIHARA Mitsuaki

  Department of Pharmacy, Yamagata University Hospital

• TOMIKE Hitonobu

  First Department of Internal Medicine, Yamagata University School of Medicine

• Tomike Hitonobu

  First Department Of Internal Medicine Yamagata University School Of Medicine

• Ebihara Mitsuaki

  Department Of Pharmacy Yamagata University Hospital

• 小島 文良

  Department of Pharmacy, Yamagata University Hospital

• 中村 秀範

  First Department of Internal Medicine, Yamagata University School of Medicine

• 海老原 光孝

  Department of Pharmacy, Yamagata University Hospital

関連論文

• Soluble Tumor Necrosis Factor Receptors are Elevated in Relation to Severity of Congestive Heart Failure
• 0945 Expression of TNF Receptor II on Mononuclear Leukocyte and Release of its Soluble Form from Mononuclear Leukocyte in Patients with Congestive Heart Failure
• -1077- Relationship between Soluble TNF Receptors and Hemodynamic Variables in Patients with Left Ventricular Disfunction(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
• -0799- Soluble Tumor Necrosis Factor (TNF) Receptors Are Correlated to Exercise Tolerance in Patients With Heart Failure(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
• -0708- Soluble TNF Receptors in Patients with Dilated Cardiomyopathy : Relation to Hemodynamic Variables and Natriuretic Peptides(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
• Two Types of soluble Tumor Necrosis Factor (TNF) Receptors Are Increased in Relation to Severity in Heart Failure
• A Comparative Study of Characteristics of Current-Type and Conventional-Type Cationic Bactericides
• Biodistribution Study of Murine Monoclonal Anti-GD_3 Antibody in Nude Mice Bearing Human Melanoma Xenografts for Development of Immunoscintigraphy
• Development of a new method for simultaneously evaluating mucociliaty clearance and pulmonary epithelial permeability in rabbit experiments by means of ^ FDG, three-dimensional positron emission tomography and rectilinear scan
• PERIPHERAL EFFECTS OF GUANFACINE COMPARED TO THOSE OF CLONIDINE THE DOG
• ON THE EXISTENCE OF METABOLIC α-ADRENERGIC RECEPTOR IN THE MYOCARDIUM
• ANALYSIS OF THE EFFECT OF AN ANTI-INFLAMMATORY STEROID, DEXAMETHASONE, ON NEUTROPHIL CHEMOTAXIS IN THE BOYDEN CHAMBER WITH A MODIFIED ^Cr-LABELING METHOD
• In Vitro Study of the Adsorption Characteristics of Drugs(Medicinal Chemistry)
• A COMPARISON OF ANTIHYPERTENSIVE EFFECTS OF ATENOLOL AND PROPRANOLOL IN THE SPONTANEOUSLY HYPERTENSIVE, DOCA/SALINE HYPERTENISVE AND RENAL HYPERTENSIVE RATS
• EFFECTS OF SEVERAL BETA-BLOCKING AGENTS ON THE DEVELOPMENT OF HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS
• ON THE HISTAMINE RECEPTOR OF THE CANINE MYOCARDIUM AND CORONARY VASCULATURE
• EFFECTS OF AMINOPHYLLINE, PROXYPHYLLINE AND A PROXYPHYLLINE-MELILOTUS EXTRACT-RUTIN MIXTURE (THEOESBERIVEN) ON THE HEART AND THE CORONARY CIRCULATION
• Effects of Coronary Vasodilators on Large and Small Coronary Arteries of Dogs
• ANTAGONISTIC EFFECTS OF TRIMETAZIDINE TO ADRENALINE
• Problems related to the titratable acidity of TPN solution products and the role of the pharmacist
• Clinical Characteristics of Asthmatic Patients Prescribed Various β-Agonist Metered-Dose Inhalers at Yamagata University Hospital
• ALPHA- AND BETA-BLOCKING ACTIVITIES OF RACEMATES OF LABETALOL
• DEVELOPMENT OF CORONARY COLLATERAL CIRCULATION IN MINIATURE SWINE AND EFFECTS OF SEVERAL DRUGS
• Effects of 2-Nicotinamidoethyl Nitrate on the Cardiovascular System
• Beta-receptor blocking potencies of the three newly synthesized .BETA.-adrenergic antagonists (S-596,K-351,N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.
• Displacement by .ALPHA.-adrenergic agonists and antagonists of 3H-prazosin bound to the .ALPHA.-adrenoceptors of the dog aorta and the rat brain.
• On the Mechanism of Hypotensive Actions of β-blockers
• Inhibition by thiamine tetrahydrofurfuryl disulfide (TTFD) of the arachidonic acid cascade-line activation as evidenced in the heart-lung preparation of the dog.
• Association of ACE Gene Polymorphisms with Coronary Artery Disease in a Northern Area of Japan.
• .ALPHA.-Blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.

もっと見る 閉じる

スポンサーリンク